Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100.
This new report from Venture Planning Group contains 1,900 pages, 820 tables and provides forecasts for 100 diseases and viruses by country and market segment, as well as sales and market shares for reagent and instrument suppliers.
The report is available by region, country, section, market segment and individual test:
Global, Europe, France, Germany, Italy, Japan, Spain, UK, USA
Assays, Competitors, Instrumentation, Technologies
Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), POC
Sexually-Transmitted Diseases (STD), Respiratory Diseases, Enteric Diseases
AIDS/HIV, Adenovirus, Aeromonads, Campylobacter, Chancroid, Chlamydia,
Cytomegalovirus, Clostridium, Coxsackievirus, Cryptosporidium, Cyclospora,
E. Coli, Echovirus, Enterovirus, Gonorrhea, Helicobacter Pylori, Hepatitis, Herpes,
Influenza, Legionella, Lyme Disease, Malaria, Measles, Meningitis, Mononucleosis,
Mycoplasma, Papillomavirus, Pneumonia, Pseudomonas, Rabies, Rhinovirus, Rotavirus,
Respiratory Syncytial Virus, Rubella, Salmonella, Septicemia, Shigella, Streptococci,
Syphilis, Toxoplasmosis, Tuberculosis, Vibrio, Yersinia.